小分子抗癌疗法开发商BlossomHill(BLSM.US)IPO定价15-17美元/股 拟筹资1.25亿美元

智通财经
Aug 04
【小分子抗癌疗法开发商BlossomHill(BLSM.US)IPO定价15-17美元/股 拟筹资1.25亿美元】智通财经APP获悉,专注于开发小分子癌症疗法、目前已进入二期临床准备阶段的生物科技公司BlossomHill Therapeutics周一公布了其首次公开募股(IPO)的发行条款。该公司计划以每股15至17美元的价格区间发行780万股股票,筹集1.25亿美元。该公司计划在纳斯达克上市,股票代码为“BLSM”。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10